Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S B Kaye

Showing results (71-80 of 411) with videos related to

Pageof 42
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1979
Potential of liposomes as drug-carriers in cancer chemotherapy: a reviewS B Kaye, V J Richardson
British Journal of Cancer|January 1, 1997
Combined inhibition of topoisomerases I and II--is this a worthwhile/feasible strategy?P A Vasey, S B Kaye
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Should we still advocate referral to specialist centres for teratoma?M J Hughes, S B Kaye
Cancer Chemotherapy and Pharmacology|January 1, 1987
Aspects of cytotoxic drug penetration, with particular reference to anthracyclinesD J Kerr, S B Kaye
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1993
What have we learnt from meta-analyses in ovarian cancer?S B Kaye, H C van Houwelingen
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Randomised controlled study of relaxation trainingS Bindemann, M Soukop, S B Kaye
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 1, 1991
Malignant pineal teratomas: a report on three patients and the case for craniospinal irradiation following chemotherapyS Senan, R Rampling, S B Kaye
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2007
Potential clinical applications of epothilones: a review of phase II studiesJ M G Larkin, S B Kaye
Lancet (London, England)|April 28, 1990
Therapy for testicular cancer in Central and Eastern EuropeP Boyle, P Maisonneuve, S B Kaye
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 18, 2006
Novel therapeutic agents in ovarian cancerR Agarwal, M Linch, S B Kaye
Pageof 42

Showing results (71-80 of 411) with videos related to

Sort By:
Pageof 42
Cancer Chemotherapy and Pharmacology|January 1, 1979
Potential of liposomes as drug-carriers in cancer chemotherapy: a reviewS B Kaye, V J Richardson
British Journal of Cancer|January 1, 1997
Combined inhibition of topoisomerases I and II--is this a worthwhile/feasible strategy?P A Vasey, S B Kaye
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Should we still advocate referral to specialist centres for teratoma?M J Hughes, S B Kaye
Cancer Chemotherapy and Pharmacology|January 1, 1987
Aspects of cytotoxic drug penetration, with particular reference to anthracyclinesD J Kerr, S B Kaye
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1993
What have we learnt from meta-analyses in ovarian cancer?S B Kaye, H C van Houwelingen
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Randomised controlled study of relaxation trainingS Bindemann, M Soukop, S B Kaye
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 1, 1991
Malignant pineal teratomas: a report on three patients and the case for craniospinal irradiation following chemotherapyS Senan, R Rampling, S B Kaye
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2007
Potential clinical applications of epothilones: a review of phase II studiesJ M G Larkin, S B Kaye
Lancet (London, England)|April 28, 1990
Therapy for testicular cancer in Central and Eastern EuropeP Boyle, P Maisonneuve, S B Kaye
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 18, 2006
Novel therapeutic agents in ovarian cancerR Agarwal, M Linch, S B Kaye
Pageof 42